This gene inhibits hepatocellular carcinoma by regulating PHF19 [30], regulates rectal cancer through CDK8, regulates osteosarcoma by inhibiting NKD1 [33], regulates prostate cancer through Fra-1 or RPS6KB1 [34]. This evidence concerns the gene CDK8 and prostate cancer.